Ubs Group Ag Treace Medical Concepts, Inc. Transaction History

Ubs Group Ag

$582 Billion
Q4 2025

A detailed history of Ubs Group Ag transactions in Treace Medical Concepts, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 293,929 shares of TMCI stock, worth $890,604. This represents 0.0% of its overall portfolio holdings.

Number of Shares

293,929

Previous 283,349 3.73%

Holding current value

$890,604

Previous $1.9 Million 53.18%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2025 Jan 29, 2026	BUY	$3.03 - $6.95 $32,057 - $73,531	10,580 Added 3.73%	293,929 $890,000
Q3 2025 Nov 13, 2025	SELL	$5.34 - $7.7 $502,483 - $724,554	-94,098 Reduced 24.93%	283,349 $1.9 Million
Q2 2025 Aug 14, 2025	BUY	$5.44 - $8.32 $87,736 - $134,184	16,128 Added 4.46%	377,447 $2.22 Million
Q1 2025 May 13, 2025	SELL	$7.3 - $10.54 $4.43 Million - $6.4 Million	-607,115 Reduced 62.69%	361,319 $3.03 Million
Q4 2024 Feb 14, 2025	BUY	$4.66 - $8.78 $4.16 Million - $7.84 Million	892,456 Added 1174.62%	968,434 $7.21 Million

Q3 2024 Nov 14, 2024	BUY	$5.01 - $8.45 $180,154 - $303,853	35,959 Added 89.85%	75,978 $440,000
Q2 2024 Aug 13, 2024	SELL	$4.17 - $12.62 $186,332 - $563,912	-44,684 Reduced 52.75%	40,019 $266,000
Q1 2024 May 13, 2024	BUY	$11.48 - $15.86 $377,737 - $521,857	32,904 Added 63.52%	84,703 $1.11 Million
Q4 2023 Feb 09, 2024	BUY	$6.03 - $12.88 $311,594 - $665,561	51,674 Added 41339.2%	51,799 $660,000
Q3 2023 Nov 09, 2023	SELL	$12.16 - $24.87 $403,699 - $825,659	-33,199 Reduced 99.62%	125 $1,000
Q2 2023 Aug 11, 2023	BUY	$23.91 - $27.81 $458,569 - $533,367	19,179 Added 135.59%	33,324 $852,000
Q1 2023 May 12, 2023	BUY	$20.23 - $26.22 $162,628 - $210,782	8,039 Added 131.66%	14,145 $356,000
Q4 2022 Feb 08, 2023	BUY	$20.54 - $24.67 $95,798 - $115,060	4,664 Added 323.44%	6,106 $140,000
Q3 2022 Nov 10, 2022	BUY	$14.71 - $24.18 $9,370 - $15,402	637 Added 79.13%	1,442 $32,000
Q2 2022 Aug 10, 2022	BUY	$12.93 - $20.29 $9,115 - $14,304	705 Added 705.0%	805 $11,000
Q1 2022 May 16, 2022	SELL	$16.73 - $21.58 $157,847 - $203,607	-9,435 Reduced 98.95%	100 $2,000
Q4 2021 Feb 14, 2022	BUY	$15.48 - $26.52 $144,134 - $246,927	9,311 Added 4156.7%	9,535 $178,000
Q3 2021 Nov 15, 2021	SELL	$24.15 - $30.5 $6,061 - $7,655	-251 Reduced 52.84%	224 $6,000
Q2 2021 Aug 13, 2021	BUY	$25.53 - $36.11 $12,126 - $17,152	475 New	475 $15,000

Others Institutions Holding TMCI

# of Institutions

117

Shares Held

58M

Call Options Held

Put Options Held

View Full List

About TREACE MEDICAL CONCEPTS, INC.

Ticker TMCI
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 55,403,300
Market Cap $168M
Description
Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical impro...

More about TMCI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account